The Home Medical Equipment Market

INTRODUCTION STUDY BACKGROUND STUDY GOALS AND OBJECTIVES INTENDED AUDIENCE SCOPE OF REPORT INFORMATION SOURCES ANALYST CREDENTIALS RELATED BCC RESEARCH BCC ONLINE SERVICES DISCLAIMER
EXECUTIVE SUMMARY: SUMMARY TABLE GLOBAL SALES OF HOME MEDICAL; EQUIPMENT, THROUGH 2012 ($ BILLIONS); SUMMARY FIGURE SALES OF HOME MEDICAL EQUIPMENT BY; REGION, 2006-2012 (%)
OVERVIEW GENERAL DESCRIPTION DEFINITIONS PRODUCT SEGMENTS ASSISTIVE DEVICES Wheelchairs and Scooters Wheelchairs Scooters Home Care Beds INFUSION PRODUCTS Insulin Pumps RESPIRATORY THERAPY PRODUCTS Inhalers Metered Dose Inhalers Dry Powder Inhalers Nebulizers Oxygen Concentrators Gaseous Oxygen System Continuous Positive Airway Pressure (CPAP) Devices Home Ventilators Suction Machines DIALYSIS EQUIPMENT Hemodialysis Dialysis Machine Peritoneal Dialysis CCPD Cycler HOME DEFIBRILLATORS MONITORS AND SENSORS Blood Pressure Monitors Aneroid Monitors Digital Blood Pressure Monitors Peak Flow Meters Glucose Monitors Glucose Monitors (Continued) Glucose Monitors (Continued) Apnea and SIDS Monitors Cholesterol Monitors Fetal Monitors Home Cardiac Monitors New Home Monitoring Technologies Embedded Monitors Wearable Monitors TELEMETRY DEVICES Telehomecare Mobile Phone-Based Technologies Bluetooth Signal Transmission via Human Skin Zigbee MISCELLANEOUS TYPES OF HME Lymphedema Pumps HEALTH CONDITIONS THAT AFFECT MARKET FOR HME MOBILITY IMPAIRMENTS Types of Mobility Impairment Paralysis Arthritis Osteoporosis Age-Related Loss of Strength/Balance/Coordination Surgical Recovery and Rehabilitation Neuromuscular Disorders HME Used to Increase Mobility Prevalence of Mobility Impairments: FIGURE 1 LEADING CONDITIONS ASSOCIATED WITH WHEELCHAIR/SCOOTER USE (PERCENTAGE OF TOTAL WHEELCHAIR USERS; FIGURE 1 (CONTINUED); TABLE 1 GLOBAL PREVALENCE OF MOTION IMPAIRMENTS REQUIRING THE USE OF A WHEELCHAIR OR SCOOTER, THROUGH 2012 (MILLIONS OF PEOPLE); TABLE 1 (CONTINUED); TABLE 2 PREVALENCE OF MOTION IMPAIRMENTS REQUIRING A WHEELCHAIR OR SCOOTER, BY REGION, THROUGH 2012 (MILLIONS OF PEOPLE)

OBESITY

HME Used in the Management of Obesity

Prevalence of Obesity; TABLE 3 OBESITY LEVELS IN SELECTED COUNTRIES (PERCENT OF ADULT POPULATION); TABLE 3 (CONTINUED)

HYPERTENSION

Types of HME Used in Treatment of Hypertension

Prevalence of Hypertension; TABLE 4 TRENDS IN PREVALENCE OF HYPERTENSION, THROUGH 2012 (MILLION CASES); TABLE 4 (CONTINUED)

CARDIOVASCULAR DISEASE

Arrhythmia

Tachyarrhythmia

Brachycardia

HME Used in the Treatment of Arrhythmia

Prevalence of Arrhythmia; TABLE 5 TRENDS IN PREVALENCE OF ARRYTHMIA, THROUGH 2012 (MILLIONS OF CASES)

DIABETES

Types of Diabetes

HME Used to Treat Diabetes

Prevalence of Diabetes and Future Trends; TABLE 6 TRENDS IN PREVALENCE OF DIABETES, THROUGH 2012 (MILLIONS OF CASES); TABLE 6 (CONTINUED)

HIGH CHOLESTEROL LEVELS

HME Used in the Management of High Cholesterol Levels

Prevalence of High Cholesterol Levels

SLEEP DISORDERS

Types of Sleep Disorders

HME Used in the Treatment or Management of Sleep

Disorders

Prevalence of Sleep Disorders and Future Trends

FETAL DISORDERS

HME Used in the Treatment or Management of Fetal

Disorders

Prevalence of Fetal Disorders and Future Trends; FIGURE 2 MISCARRIAGES AND STILLBIRTHS IN THE UNITED STATES, 2004 (PERCENT OF TOTAL CONFIRMED PREGNANCIES)

ASTHMA

HME Used in the Treatment or Management of Asthma

Prevalence of Asthma and Future Trends; TABLE 7 TRENDS IN PREVALENCE OF ASTHMA, THROUGH 2012 (MILLION CASES)

CHRONIC OBSTRUCTIVE PULMONARY DISEASE

HME Used in the Treatment or Management of COPD

Prevalence of COPD and Future Trends

KIDNEY FAILURE

HME Used in the Treatment of Kidney Failure

Prevalence of Kidney Failure and Future Trends; TABLE 8 TRENDS IN DIALYSIS PATIENT POPULATION, THROUGH 2012 (THOUSAND PEOPLE); TABLE 8 (CONTINUED); FIGURE 3 GLOBAL DIALYSIS PATIENT POPULATION TREND, 2006-2012 (MILLION PATIENTS)

LYMPHEDEMA

Types of Lymphedema

Primary Lymphedema

Secondary Lymphedema

HME Used in the Management of Lymphedema

Prevalence of Lymphedema

DEMOGRAPHICS AND ECONOMICS

TOTAL POPULATION; FIGURE 4 GLOBAL POPULATION TRENDS, 2006-2012 (BILLION PEOPLE); FIGURE 5 G-20 POPULATION AS PERCENTAGE OF TOTAL WORLD POPULATION, 2006 AND 2012 (%); TABLE 9 TRENDS IN TOTAL POPULATION, BY COUNTRY THROUGH 2012 (MILLIONS); TABLE 9 (CONTINUED)

ELDERLY PEOPLE; FIGURE 6 TRENDS IN THE GLOBAL POPULATION AGED 65 YEARS AND OLDER, 2006-2012 (MILLION PEOPLE); FIGURE 7 G-20 POPULATION AS PERCENTAGE OF WORLD POPULATION 65 AND OLDER, 2006 AND 2012 (%); TABLE 10 TRENDS IN POPULATION 65 YEARS AND OLDER, BY COUNTRY THROUGH 2012 (MILLIONS); TABLE 10 (CONTINUED)

OLDER PEOPLE LIVING IN OWN HOMES OR WITH

CHILDREN; FIGURE 8 PERCENTAGE OF PEOPLE 65 AND OVER LIVNG IN OWN HOMES OR WITH CHILDREN, 2002; FIGURE 8 (CONTINUED); FIGURE 9 TRENDS IN THE PERCENTAGE OF AMERICANS OVER 65 REMAINING IN THEIR HOMES, 1985-2005 (%)

HOUSEHOLD INCOME; FIGURE 10 TRENDS IN MEDIAN INCOME OF U.S. ELDERLY HOUSEHOLDS ($); FIGURE 11 DISTRIBUTION OF U.S. ELDERLY HOUSEHOLDS BY INCOME LEVEL, 2000 VS. 2006 (PERCENT OF TOTAL ELDERLY HOUSEHOLDS)

EXPENDITURES ON HOME HEALTH CARE; FIGURE 12 TRENDS IN U.S. EXPENDITURES ON HOME HEALTH CARE, 2000-2005* ($ BILLIONS)

OTHER FACTORS DRIVING HME MARKET

PHYSICIAN ATTITUDES TOWARD HOME CARE; FIGURE 13 TREND IN NUMBER OF MEDICARE-PAID PHYSICIAN HOUSE CALLS, 2001-2005 (MILLION HOUSE CALLS)

HOSPITAL/NURSING HOME COSTS; FIGURE 14 TRENDS IN U.S. HOSPITAL AND NURSING HOME COSTS SINCE 2000 ($)

REGULATORY AND LEGISLATIVE ISSUES

United States

New Devices

New Devices (Continued)

Existing Devices

European Union

European Union (Continued)

Japan

HEALTH INSURANCE

United States

Medicare and Medicaid

Types of HME Covered

Recent Legislation

Medicare Prescription Drug,

Improvement, and Modernization

Act of 2003

Changes in Reimbursement

Competitive Bidding

Accreditation Requirement

Deficit Reduction Act of 2005

Challenges

Other Countries; FIGURE 15 PER CAPITA EXPENDITURES ON HME, 2006 ($)

Other Countries (Continued)

HME MARKETS

SUMMARY

GLOBAL MARKET TRENDS; TABLE 11 GLOBAL HME SALES BY TYPE OF EQUIPMENT, THROUGH 2012 ($ MILLIONS); FIGURE 16 TRENDS IN THE GLOBAL HME MARKET, 2006-2012 ($ BILLIONS)

MARKET BY HME SEGMENT; FIGURE 17 HME MARKET BY TYPE OF HME, 2006 AND 2012 (%)

MARKET BY DISEASE/CONDITION TREATED; FIGURE 18 HME MARKET BY TYPE OF DISEASE/CONDITION TREATED, 2006 AND 2012; FIGURE 18 (CONTINUED); TABLE 12 HME MARKET BY TYPE OF DISEASE/CONDITION TREATED, THROUGH 2012 ($ MILLIONS)

MARKET BY GEOGRAPHICAL SEGMENT; FIGURE 19 HME MARKET BY TYPE OF REGION, 2006 AND 2012 (%); FIGURE 19 (CONTINUED); TABLE 13 MAJOR GEOGRAPHICAL MARKETS FOR HME, THROUGH 2012; TABLE 13 (CONTINUED)

DETAILED MARKET ANALYSIS

ASSISTIVE DEVICES; TABLE 14 MARKET FOR HME ASSISTIVE DEVICES, THROUGH 2012 ($ MILLIONS)

Wheelchairs and Scooters; FIGURE 20 GLOBAL WHEELCHAIR AND SCOOTER MARKET SHARES BY TYPE OF EQUIPMENT, 2006 (%); FIGURE 20 (CONTINUED); TABLE 15 GLOBAL WHEELCHAIR AND SCOOTER SALES, 2006 (MILLION UNITS/$ MILLIONS); TABLE 16 GLOBAL MARKET FOR WHEELCHAIRS AND SCOOTERS USED IN THE HOME, BY GEOGRAPHICAL MARKET, 2006-2012 ($ MILLIONS)

Home Care Beds; TABLE 17 GLOBAL MARKET FOR HOME CARE BEDS, BY GEOGRAPHICAL MARKET, THROUGH 2012 ($ MILLIONS)

INFUSION PRODUCTS

Insulin Pumps; TABLE 18 INSULIN PUMP SALES, THROUGH 2012 (NUMBER OF PUMPS/$ MILLIONS); TABLE 19 PROJECTED SALES OF INSULIN PUMPS, THROUGH 2012 ($ MILLIONS)

RESPIRATORY THERAPY PRODUCTS; TABLE 20 MARKET FOR RESPIRATORY HME, THROUGH 2012 ($ MILLIONS); FIGURE 21 TRENDS IN RESPIRATORY HME MARKET SHARES BY TYPE OF EQUIPMENT, 2006-2012 (PERCENT OF TOTAL RESPIRATORY HME SALES); FIGURE 22 TRENDS IN RESPIRATORY HME MARKET SHARES BY GEOGRAPHICAL MARKET, 2006-2012 (PERCENT OF TOTAL RESPIRATORY HME SALES)

Insulin Inhalers; TABLE 21 PROJECTED SALES OF INSULIN INHALERS, THROUGH 2012 ($ MILLIONS); TABLE 21 (CONTINUED)

CPAP and Other Positive Airway Pressure Devices; TABLE 22 POSITIVE AIR PRESSURE DEVICES MARKET, THROUGH 2012 ($ MILLIONS); TABLE 22 (CONTINUED)

Ventilators; TABLE 23 GLOBAL HOME VENTILATOR MARKET, THROUGH 2012 ($ MILLIONS)

Nebulizers; TABLE 24 GLOBAL NEBULIZER MARKET, THROUGH 2012 ($ MILLIONS)

Oxygen Concentrators; TABLE 25 GLOBAL HOME OXYGEN CONCENTRATOR MARKET, THROUGH 2012 ($ MILLIONS)

Gaseous Oxygen Systems; TABLE 26 GLOBAL MARKET FOR HOME GASEOUS OXYGEN SYSTEMS, THOUGH 2012 ($ MILLIONS)

Airway Suction Machines; TABLE 27 GLOBAL HOME SUCTION MACHINE MARKET, THROUGH 2012 ($ MILLIONS)

DIALYSIS EQUIPMENT; FIGURE 23 HOME DIALYSIS MACHINE MARKET SHARES, 2006 (%); TABLE 28 GLOBAL MARKET FOR HOME DIALYSIS MACHINES, 2006 (NUMBER OF MACHINES/$); TABLE 29 HOME DIALYSIS MACHINE MARKET, THROUGH 2012 ($ MILLIONS); TABLE 29 (CONTINUED)

HOME DEFIBRILLATORS; TABLE 30 GLOBAL HOME DEFIBRILLATOR MARKET, THROUGH 2012 ($ MILLIONS)

MONITORS AND SENSORS; TABLE 31 MARKET FOR HOME MONITORING DEVICES, THROUGH 2012 ($ MILLIONS); FIGURE 24 TRENDS IN HOME MONITORING EQUIPMENT SHARES BY TYPE OF EQUIPMENT, 2006-2012 (PERCENT OF TOTAL RESPIRATORY HME SALES); FIGURE 25 TRENDS IN HOME MONITORING DEVICES MARKET SHARES BY GEOGRAPHICAL MARKET, 2006-2012 (PERCENT OF TOTAL HOME MONITOR SALES)

Glucose Monitors; TABLE 32 MARKETS FOR GLUCOSE SELF-MONITORING DEVICES, THROUGH 2012 ($ MILLIONS); TABLE 32 (CONTINUED)

Blood Pressure Monitors; TABLE 33 MARKETS FOR HOME BLOOD PRESSURE MONITORS, THROUGH 2012 ($ MILLIONS); TABLE 33 (CONTINUED)

Apnea and Other Types of Sleep Monitors; TABLE 34 SLEEP APNEA MONITOR MARKET, 2006-2012 ($ MILLIONS)

Cholesterol Monitors; TABLE 35 CHOLESTEROL MONITOR MARKET, THROUGH 2012 ($ MILLIONS)

Fetal Monitors; TABLE 36 HOME FETAL MONITOR MARKET, THROUGH 2012 ($ MILLIONS)

Peak Flow (Asthma) Monitors; TABLE 37 GLOBAL ASTHMA MONITOR MARKET, THROUGH 2012 ($ MILLIONS)

Home ECG Monitors; TABLE 38 GLOBAL HOME ECG MONITOR MARKET, THROUGH 2012 ($ MILLIONS)

TELEMETRY DEVICES; FIGURE 26 HOME TELEMETRY DEVICE SALES BY GEOGRAPHICAL MARKET, 2006 (PERCENT OF TOTAL SALES); TABLE 39 GLOBAL MARKET FOR HOME TELEMETRY DEVICES, THROUGH 2012 ($ MILLIONS)

OTHER TYPES OF HME; TABLE 40 GLOBAL MARKET FOR LYMPHEDEMA PUMPS, THROUGH 2012 ($ MILLIONS)
PATENT ANALYSIS: TABLE 41 U.S. HME PATENTS ISSUED SINCE 1975; FIGURE 27 U.S. HME PATENTS ISSUED SINCE 1975 (%); FIGURE 28 LARGEST HME PATENT HOLDERS (PERCENT OF TOTAL HME PATENTS ISSUED THROUGH 10/1/2007)
COMPANY PROFILES A&D MEDICAL/LIFESOURCE ABBOTT LABORATORIES, INC ALLIED HEALTH CARE PRODUCTS, INC. ANALOGIC INC. ARADIGM CORP ARITHMED GMBH BAXTER INTERNATIONAL, INC. BAYER DIAGNOSTICS CARD GUARD AG ENERGY-LAB TECHNOLOGIES GMBH T+MEDICAL FRESENIUS MEDICAL CARE AG & CO. KGAA HEALTH FRONTIER, INC HOME DIAGNOSTICS INC HOMMED LLC INVACARE CORP. MEDLINE INDUSTRIES, INC MEDTRONIC MINIMED MEDVITAL NXSTAGE MEDICAL, INC NIR DIAGNOSTICS INC NONIN MEDICAL, INC OMRON HEALTHCARE, INC P2P HEALTH SYSTEMS, INC. PARI PHARMA PENDRAGON MEDICAL LTD PFIZER INC PHILIPS MEDICAL SYSTEMS POLYMER TECHNOLOGY SYSTEMS PREMD INC PRIDE MOBILITY PRODUCTS CORP PULSE METRIC INC. RESMED, INC. RESPIRONICS, INC ROCHE DIAGNOSTICS RTX TELECOM A/S SCOTTCARE CORP. SENSATEX INC. SENSITRON INC. SONTRA MEDICAL CORP TELZUIT MEDICAL TECHNOLOGIES, INC. VECTURA GROUP PLC VIVOMETRICS INC VIVOMETRICS INC. (CONTINUED)
LIST OF TABLES: SUMMARY TABLE GLOBAL SALES OF HOME MEDICAL; EQUIPMENT, THROUGH 2012 ($ BILLIONS); TABLE 1 GLOBAL PREVALENCE OF MOTION IMPAIRMENTS; REQUIRING THE USE OF A WHEELCHAIR OR SCOOTER, THROUGH; 2012 (MILLIONS OF PEOPLE); TABLE 2 PREVALENCE OF MOTION IMPAIRMENTS REQUIRING A; WHEELCHAIR OR SCOOTER, BY REGION, THROUGH 2012; (MILLIONS OF PEOPLE); TABLE 3 OBESITY LEVELS IN SELECTED COUNTRIES (PERCENT OF; ADULT POPULATION); TABLE 4 TRENDS IN PREVALENCE OF HYPERTENSION, THROUGH; 2012 (MILLION CASES); TABLE 5 TRENDS IN PREVALENCE OF ARRYTHMIA, THROUGH 2012; (MILLIONS OF CASES); TABLE 6 TRENDS IN PREVALENCE OF DIABETES, THROUGH 2012; (MILLIONS OF CASES); TABLE 7 TRENDS IN PREVALENCE OF ASTHMA, THROUGH 2012; (MILLIONS OF CASES); TABLE 8 TRENDS IN DIALYSIS PATIENT POPULATION, THROUGH; 2012 (THOUSAND PEOPLE); TABLE 9 TRENDS IN TOTAL POPULATION, BY COUNTRY THROUGH; 2012 (MILLIONS); TABLE 10 TRENDS IN POPULATION 65 YEARS AND OLDER, BY; COUNTRY THROUGH 2012 (MILLIONS); TABLE 11 GLOBAL HME SALES BY TYPE OF EQUIPMENT, THROUGH; 2012 ($ MILLIONS); TABLE 12 HME MARKET BY TYPE OF DISEASE/CONDITION; TREATED, THROUGH 2012 ($ MILLIONS); TABLE 13 MAJOR GEOGRAPHICAL MARKETS FOR HME, THROUGH; 2012; TABLE 14 MARKET FOR HME ASSISTIVE DEVICES, THROUGH 2012; ($ MILLIONS); TABLE 15 GLOBAL WHEELCHAIR AND SCOOTER SALES, 2006; (MILLION UNITS/$ MILLIONS); TABLE 16 GLOBAL MARKET FOR WHEELCHAIRS AND SCOOTERS; USED IN THE HOME, BY GEOGRAPHICAL MARKET, 2006-2012; ($ MILLIONS); TABLE 17 GLOBAL MARKET FOR HOME CARE BEDS, BY; GEOGRAPHICAL MARKET, THROUGH 2012 ($ MILLIONS); TABLE 18 INSULIN PUMP SALES, THROUGH 2012 (NUMBER OF; PUMPS/$ MILLIONS); TABLE 19 PROJECTED SALES OF INSULIN PUMPS, THROUGH 2012; ($ MILLIONS); TABLE 20 MARKET FOR RESPIRATORY HME, THROUGH 2012; ($ MILLIONS); TABLE 21 PROJECTED SALES OF INSULIN INHALERS, THROUGH; 2012 ($ MILLIONS); TABLE 22 POSITIVE AIR PRESSURE DEVICES MARKET, THROUGH; 2012 ($ MILLIONS); TABLE 23 GLOBAL HOME VENTILATOR MARKET, THROUGH 2012; ($ MILLIONS); TABLE 24 GLOBAL NEBULIZER MARKET, THROUGH 2012; ($ MILLIONS); TABLE 25 GLOBAL HOME OXYGEN CONCENTRATOR MARKET,; THROUGH 2012 ($ MILLIONS); TABLE 26 GLOBAL MARKET FOR HOME GASEOUS OXYGEN; SYSTEMS, THOUGH 2012 ($ MILLIONS); TABLE 27 GLOBAL HOME SUCTION MACHINE MARKET, THROUGH; 2012 ($ MILLIONS); TABLE 28 GLOBAL MARKET FOR HOME DIALYSIS MACHINES, 2006; (NUMBER OF MACHINES/$); TABLE 29 HOME DIALYSIS MACHINE MARKET, THROUGH 2012; ($ MILLIONS); TABLE 30 GLOBAL HOME DEFIBRILLATOR MARKET, THROUGH 2012; ($ MILLIONS); TABLE 31 MARKET FOR HOME MONITORING DEVICES, THROUGH; 2012 ($ MILLIONS); TABLE 32 MARKETS FOR GLUCOSE SELF-MONITORING DEVICES,; THROUGH 2012 ($ MILLIONS); TABLE 33 MARKETS FOR HOME BLOOD PRESSURE MONITORS,; THROUGH 2012 ($ MILLIONS); TABLE 34 SLEEP APNEA MONITOR MARKET, 2006-2012 ($ MILLIONS); TABLE 35 CHOLESTEROL MONITOR MARKET, THROUGH 2012; ($ MILLIONS); TABLE 36 HOME FETAL MONITOR MARKET, THROUGH 2012; ($ MILLIONS); TABLE 37 GLOBAL ASTHMA MONITOR MARKET, THROUGH 2012; ($ MILLIONS); TABLE 38 GLOBAL HOME ECG MONITOR MARKET, THROUGH 2012; ($ MILLIONS); TABLE 39 GLOBAL MARKET FOR HOME TELEMETRY DEVICES,; THROUGH 2012 ($ MILLIONS); TABLE 40 GLOBAL MARKET FOR LYMPHEDEMA PUMPS, THROUGH; 2012 ($ MILLIONS); TABLE 41 U.S. HME PATENTS ISSUED SINCE 1975
LIST OF FIGURES: SUMMARY FIGURE SALES OF HOME MEDICAL EQUIPMENT BY; REGION, 2006-2012 (%); FIGURE 1 LEADING CONDITIONS ASSOCIATED WITH; WHEELCHAIR/SCOOTER USE (PERCENTAGE OF TOTAL; WHEELCHAIR USERS; FIGURE 2 MISCARRIAGES AND STILLBIRTHS IN THE UNITED; STATES, 2004 (PERCENT OF TOTAL CONFIRMED PREGNANCIES); FIGURE 3 GLOBAL DIALYSIS PATIENT POPULATION TREND, 2006-; 2012 (MILLION PATIENTS); FIGURE 4 GLOBAL POPULATION TRENDS, 2006-2012 (BILLION; PEOPLE); FIGURE 5 G-20 POPULATION AS PERCENTAGE OF TOTAL WORLD; POPULATION, 2006 AND 2012 (%); FIGURE 6 TRENDS IN THE GLOBAL POPULATION AGED 65 YEARS; AND OLDER, 2006-2012 (MILLION PEOPLE); FIGURE 7 G-20 POPULATION AS PERCENTAGE OF WORLD; POPULATION 65 AND OLDER, 2006 AND 2012 (%); FIGURE 8 PERCENTAGE OF PEOPLE 65 AND OVER LIVNG IN OWN; HOMES OR WITH CHILDREN, 2002; FIGURE 9 TRENDS IN THE PERCENTAGE OF AMERICANS OVER 65; REMAINING IN THEIR HOMES, 1985-2005 (%); FIGURE 10 TRENDS IN MEDIAN INCOME OF U.S. ELDERLY; HOUSEHOLDS ($); FIGURE 11 DISTRIBUTION OF U.S. ELDERLY HOUSEHOLDS BY; INCOME LEVEL, 2000 VS. 2006 (PERCENT OF TOTAL ELDERLY; HOUSEHOLDS); FIGURE 12 TRENDS IN U.S. EXPENDITURES ON HOME HEALTH; CARE, 2000-2005* ($ BILLIONS); FIGURE 13 TREND IN NUMBER OF MEDICARE-PAID PHYSICIAN; HOUSE CALLS, 2001-2005 (MILLION HOUSE CALLS); FIGURE 14 TRENDS IN U.S. HOSPITAL AND NURSING HOME COSTS; SINCE 2000 ($); FIGURE 15 PER CAPITA EXPENDITURES ON HME, 2006 ($); FIGURE 16 TRENDS IN THE GLOBAL HME MARKET, 2006-2012; ($ BILLIONS); FIGURE 17 HME MARKET BY TYPE OF HME, 2006 AND 2012 (%); FIGURE 18 HME MARKET BY TYPE OF DISEASE/CONDITION; TREATED, 2006 AND 2012; FIGURE 19 HME MARKET BY TYPE OF REGION, 2006 AND 2012 (%); FIGURE 20 GLOBAL WHEELCHAIR AND SCOOTER MARKET SHARES; BY TYPE OF EQUIPMENT, 2006 (%); FIGURE 21 TRENDS IN RESPIRATORY HME MARKET SHARES BY; TYPE OF EQUIPMENT, 2006-2012 (PERCENT OF TOTAL; RESPIRATORY HME SALES); FIGURE 22 TRENDS IN RESPIRATORY HME MARKET SHARES BY; GEOGRAPHICAL MARKET, 2006-2012 (PERCENT OF TOTAL; RESPIRATORY HME SALES); FIGURE 23 HOME DIALYSIS MACHINE MARKET SHARES, 2006 (%); FIGURE 24 TRENDS IN HOME MONITORING EQUIPMENT SHARES; BY TYPE OF EQUIPMENT, 2006-2012 (PERCENT OF TOTAL; RESPIRATORY HME SALES); FIGURE 25 TRENDS IN HOME MONITORING DEVICES MARKET; SHARES BY GEOGRAPHICAL MARKET, 2006-2012 (PERCENT OF; TOTAL HOME MONITOR SALES); FIGURE 26 HOME TELEMETRY DEVICE SALES BY GEOGRAPHICAL; MARKET, 2006 (PERCENT OF TOTAL SALES); FIGURE 27 U.S. HME PATENTS ISSUED SINCE 1975 (%); FIGURE 28 LARGEST HME PATENT HOLDERS (PERCENT OF TOTAL; HME PATENTS ISSUED THROUGH 10/1/2007)